Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms

Eitemau Tebyg

• Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
  gan: Lashley, D, et al.
  Cyhoeddwyd: (2010)
• EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
  gan: Lashley, D, et al.
  Cyhoeddwyd: (2009)
• Clinical features of the DOK7 neuromuscular junction synaptopathy.
  gan: Palace, J, et al.
  Cyhoeddwyd: (2007)
• The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
  gan: Beeson, D, et al.
  Cyhoeddwyd: (2012)
• The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells
  gan: Spearman, H, et al.
  Cyhoeddwyd: (2008)